Literature DB >> 14639017

Correlation of connexin43 expression and late ventricular potentials in nonischemic dilated cardiomyopathy.

Hidetsuna Kitamura1, Akihiro Yoshida, Yoshio Ohnishi, Katsunori Okajima, Akihiko Ishida, Erdulfo J Galeano, Shinya Kubo, Kouji Fukuzawa, Takatsugu Takano, Mitsuhiro Yokoyama.   

Abstract

Nonischemic dilated cardiomyopathy (DCM) is associated with a high risk of sudden cardiac death. Signal-averaged electrocardiography (SAECG) is a useful clinical tool for detecting late ventricular potentials (LP). Gap junction alterations have recently been shown to be involved in the pathogenesis of ventricular arrhythmias in DCM; however, the possible relationship between gap junctional connexin43 (C x 43) expression and SAECG has not yet been evaluated. In the present study 16 patients (47+/-13 years) with DCM who had undergone SAECG testing were evaluated. In each patient, the expression of C x 43 proteins was qualitatively and quantitatively determined using immunoconfocal microscopy and right ventricular biopsy specimens. The level of expression of C x 43 protein was defined as the proportion of tissue area occupied by C x 43 (percent tissue area) in each test area. The abundance and distribution of the C x 43 signal was assessed in relation to LP. Late ventricular potentials were positive in 5 patients (LP (+) group) and negative in 11 patients (LP (-) group). The incidence of sustained ventricular tachycardia in the LP (+) group was higher than that in the LP (-) group (80% vs 18%, p=0.04). The percent tissue area of C x 43 in the LP (+) group was significantly lower than that in the LP (-) group (p=0.02). Furthermore, C x 43 protein in the LP (+) group was distributed more heterogeneously than that in the LP (-) group (p=0.001). The heterogeneous expression of C x 43 protein may contribute to impaired ventricular conduction, which may be related to the LP detected on SAECG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639017     DOI: 10.1253/circj.67.1017

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.

Authors:  Dorothea Rosenberger; Karni S Moshal; Ganesh K Kartha; Neetu Tyagi; Utpal Sen; David Lominadze; Claudio Maldonado; Andrew M Roberts; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

2.  Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.

Authors:  Srikanth Givvimani; Natia Qipshidze; Neetu Tyagi; Paras K Mishra; Utpal Sen; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-05-29

3.  Changes in arrhythmogenic properties and five-year prognosis after carbon-ion radiotherapy in patients with mediastinum cancer.

Authors:  Mari Amino; Koichiro Yoshioka; Makiyoshi Shima; Tohru Okada; Mio Nakajima; Yoshiya Furusawa; Shigetaka Kanda; Sadaki Inokuchi; Teruhisa Tanabe; Yuji Ikari; Tadashi Kamada
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-06-07       Impact factor: 1.468

4.  Mammalian enabled (Mena) is a critical regulator of cardiac function.

Authors:  Frédérick Aguilar; Stephen L Belmonte; Rashmi Ram; Sami F Noujaim; Olga Dunaevsky; Tricia L Protack; Jose Jalife; H Todd Massey; Frank B Gertler; Burns C Blaxall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

5.  Immunohistochemical evaluation of cardiac connexin43 in rats exposed to low-frequency noise.

Authors:  Eduardo Antunes; Gonçalo Borrecho; Pedro Oliveira; José Brito; Artur Águas; José Martins dos Santos
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 6.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

Review 7.  Passive ventricular remodeling in cardiac disease: focus on heterogeneity.

Authors:  Elise L Kessler; Mohamed Boulaksil; Harold V M van Rijen; Marc A Vos; Toon A B van Veen
Journal:  Front Physiol       Date:  2014-12-22       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.